Avorix

Avorix

entecavir

Manufacturer:

Novugen Pharma

Distributor:

Novugen Pharma
Concise Prescribing Info
Contents
Entecavir
Indications/Uses
Chronic HBV infection in adults w/ evidence of active viral replication & either evidence of persistent elevations in serum aminotransferases (ALT/AST) or histologically active disease.
Dosage/Direction for Use
Compensated liver disease Nucleoside-naive patient 0.5 mg once daily. Lamivudine-refractory patient 1 mg once daily. Decompensated liver disease 1 mg once daily.
Administration
Should be taken on an empty stomach: In nucleoside naive patients w/ compensated liver disease, take w/ or w/o meals. For patients w/ decompensated liver disease & lamivudine-refractory patients w/ compensated liver disease, take on an empty stomach (at least 2 hr before & at least 2 hr after a meal).
Contraindications
Special Precautions
Not recommended for HIV/HBV co-infected patients not receiving highly active antiretroviral therapy. Not proven to reduce HBV transmission. Lactic acidosis/hepatomegaly w/ steatosis. Monitor hepatic function at repeated intervals after discontinuation. Evaluate renal function prior to & during therapy in liver transplant recipients receiving cyclosporine or tacrolimus. Closely monitor clinical & lab parameters in patients w/ decompensated liver disease. May affect ability to drive & use machines. Renal impairment. Pregnancy. Not to be used during lactation. Ped patients <16 yr.
Adverse Reactions
Headache; fatigue; diarrhea, dysgeusia.
Drug Interactions
Increased serum conc w/ products reducing renal function or competing for active tubular secretion. Decreased absorption w/ food.
MIMS Class
Antivirals
ATC Classification
J05AF10 - entecavir ; Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
Presentation/Packing
Form
Avorix FC tab 0.5 mg
Packing/Price
1 × 10's;10 × 10's;100 × 10's;3 × 10's;50 × 10's;6 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in